Anemia in myelofibrosis significantly affects survival and quality of life, with severe anemia reducing median survival ...

Learn about Myelofibrosis, its symptoms, causes, diagnosis, and treatment options, including medication, stem cell transplant ...

Ojjaara helps patients with myelofibrosis by reducing spleen size, easing symptoms, and improving anemia to boost independence from blood transfusions. Ojjaara (momelotinib) is the first treatment of ...

PLANEGG and MUNICH, GERMANY / ACCESSWIRE / November 20, 2023 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announces strong topline results from the Phase 3 MANIFEST-2 study investigating pelabresib, an ...

Syntara (ASX:SNT) is advancing multiple Phase 2 studies with its lead drug amsulostat, showing standout results in ...